MiNK Therapeutics Reports First Quarter 2026 Financial Results as iNKT Cell Therapy Platform Enters Randomized Clinical Trials DHC2042Notes DHCNI Q1 2026 Earnings Miss by Significant Key Takeaways Jim Cramer Bond Markets Wrath Could Smack Down Stocks Amid Rising Yields and Oil Surge Nuveen SP SPXX Slips 100 Testing 1692 Support 20260515 Ready Capital Corporation RC Q1 2026 Earnings Massive EPS Miss Signals Severe Challenges FTEK Q1 2026 Earnings EPS Miss as Company Reports a Loss CSX Q1 2026 Earnings EPS Beats Estimates by 925 as Stock Slips Workhorse Group Q1 2026 Earnings EPS Miss Widens as Company Remains PreRevenue PENN Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher AII Q1 2026 Earnings Earnings Beat Expectations Amid Strong Underwriting Performance